VTAK Valuation

Catheter Precision Inc

Add to Watchlist

Advanced Chart

0.270

+0.001(+0.370%)

Overview
Forecast
Valuation

VTAK Relative Valuation

VTAK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, VTAK is overvalued; if below, it's undervalued.

Historical Valuation

Catheter Precision Inc (VTAK) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.66 is considered Undervalued compared with the five-year average of 0.50. The fair price of Catheter Precision Inc (VTAK) is between 0.37 to 0.68 according to relative valuation methord. Compared to the current price of 0.27 USD , Catheter Precision Inc is Undervalued By 27.55%.

Relative Value

Fair Zone

0.37-0.68

Current Price：0.27

27.55%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.18

P/B

Median3y

0.19

Median5y

0.19

-373.14

FCF Yield

Median3y

-460.74

Median5y

-460.74

Competitors Valuation Multiple

The average P/S ratio for VTAK's competitors is 2.73, providing a benchmark for relative valuation. Catheter Precision Inc Corp (VTAK) exhibits a P/S ratio of 0.66, which is -75.97% above the industry average. Given its robust revenue growth of 16.41%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

VTAK.A

Catheter Precision Inc

0.66

Average P/S: 2.73

16.41%